Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo

Osteosarcoma (OS) is a malignant primary bone tumor with high metastatic rate. C-X-C motif chemokine ligand 6 (CXCL6) and its receptor C-X-C motif chemokine receptor 1/2 (CXCR1/2) have been found to participate in the process of carcinogenesis. In this study, we evaluated the role of CXCL6/CXCR1/2 a...

Full description

Bibliographic Details
Main Authors: Guangchen Liu, Liping An, Hongmei Zhang, Peige Du, Yu Sheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00307/full
_version_ 1818108738556395520
author Guangchen Liu
Liping An
Hongmei Zhang
Peige Du
Yu Sheng
author_facet Guangchen Liu
Liping An
Hongmei Zhang
Peige Du
Yu Sheng
author_sort Guangchen Liu
collection DOAJ
description Osteosarcoma (OS) is a malignant primary bone tumor with high metastatic rate. C-X-C motif chemokine ligand 6 (CXCL6) and its receptor C-X-C motif chemokine receptor 1/2 (CXCR1/2) have been found to participate in the process of carcinogenesis. In this study, we evaluated the role of CXCL6/CXCR1/2 axis in proliferation and metastasis of OS cells. According to our results, the mRNA and protein expressions of CXCL6, CXCR1, and CXCR2 in multiple OS cell lines were determined. Treatment with exogenous CXCL6 for more than 72 h significantly promoted the proliferation of OS cells. Blocking the effect of endogenous CXCL6 restrained the migration, invasion and epithelial-mesenchymal transition (EMT) as evidenced by increased E-cadherin level, decreased N-cadherin and Snail levels in OS cells. On the contrary, exogenous CXCL6 administration enhanced the migration and invasive abilities of OS cells. Moreover, silencing of CXCR1/2 suppressed migration, invasion and EMT of OS cells with or without treatment with exogenous CXCL6. In addition, exogenous CXCL6 promoted the activation of PI3K/AKT and β-catenin signaling pathways, which could be repressed by CXCR2 knockdown. Inactivation of PI3K/AKT or β-catenin pathway by specific inhibitors effectively suppressed CXCL6-induced migration, invasion and EMT of OS cells. Finally, overexpression of CXCL6 significantly contributed to tumor growth, pulmonary metastasis and activation of PI3K/AKT and β-catenin pathways in nude mice in vivo, which were repressed by treatment with CXCR2 antagonist. Our results suggest that CXCL6/CXCR1/2 axis promotes the proliferation and metastasis of OS cells.
first_indexed 2024-12-11T02:20:08Z
format Article
id doaj.art-9e6314d1831c45e094af96a9422810ab
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T02:20:08Z
publishDate 2019-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-9e6314d1831c45e094af96a9422810ab2022-12-22T01:24:04ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-03-011010.3389/fphar.2019.00307436912Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivoGuangchen Liu0Liping An1Hongmei Zhang2Peige Du3Yu Sheng4Department of Traumatic Orthopedics, The First Hospital of Jilin University, Changchun, ChinaCollege of Pharmacy, Beihua University, Jilin, ChinaDepartment of Pharmacy, The First Hospital of Jilin University, Changchun, ChinaCollege of Pharmacy, Beihua University, Jilin, ChinaCollege of Pharmacy, Beihua University, Jilin, ChinaOsteosarcoma (OS) is a malignant primary bone tumor with high metastatic rate. C-X-C motif chemokine ligand 6 (CXCL6) and its receptor C-X-C motif chemokine receptor 1/2 (CXCR1/2) have been found to participate in the process of carcinogenesis. In this study, we evaluated the role of CXCL6/CXCR1/2 axis in proliferation and metastasis of OS cells. According to our results, the mRNA and protein expressions of CXCL6, CXCR1, and CXCR2 in multiple OS cell lines were determined. Treatment with exogenous CXCL6 for more than 72 h significantly promoted the proliferation of OS cells. Blocking the effect of endogenous CXCL6 restrained the migration, invasion and epithelial-mesenchymal transition (EMT) as evidenced by increased E-cadherin level, decreased N-cadherin and Snail levels in OS cells. On the contrary, exogenous CXCL6 administration enhanced the migration and invasive abilities of OS cells. Moreover, silencing of CXCR1/2 suppressed migration, invasion and EMT of OS cells with or without treatment with exogenous CXCL6. In addition, exogenous CXCL6 promoted the activation of PI3K/AKT and β-catenin signaling pathways, which could be repressed by CXCR2 knockdown. Inactivation of PI3K/AKT or β-catenin pathway by specific inhibitors effectively suppressed CXCL6-induced migration, invasion and EMT of OS cells. Finally, overexpression of CXCL6 significantly contributed to tumor growth, pulmonary metastasis and activation of PI3K/AKT and β-catenin pathways in nude mice in vivo, which were repressed by treatment with CXCR2 antagonist. Our results suggest that CXCL6/CXCR1/2 axis promotes the proliferation and metastasis of OS cells.https://www.frontiersin.org/article/10.3389/fphar.2019.00307/fullosteosarcomaCXCL6/CXCR1/2 axismetastasisPI3K/AKTβ-catenin
spellingShingle Guangchen Liu
Liping An
Hongmei Zhang
Peige Du
Yu Sheng
Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
Frontiers in Pharmacology
osteosarcoma
CXCL6/CXCR1/2 axis
metastasis
PI3K/AKT
β-catenin
title Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
title_full Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
title_fullStr Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
title_full_unstemmed Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
title_short Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
title_sort activation of cxcl6 cxcr1 2 axis promotes the growth and metastasis of osteosarcoma cells in vitro and in vivo
topic osteosarcoma
CXCL6/CXCR1/2 axis
metastasis
PI3K/AKT
β-catenin
url https://www.frontiersin.org/article/10.3389/fphar.2019.00307/full
work_keys_str_mv AT guangchenliu activationofcxcl6cxcr12axispromotesthegrowthandmetastasisofosteosarcomacellsinvitroandinvivo
AT lipingan activationofcxcl6cxcr12axispromotesthegrowthandmetastasisofosteosarcomacellsinvitroandinvivo
AT hongmeizhang activationofcxcl6cxcr12axispromotesthegrowthandmetastasisofosteosarcomacellsinvitroandinvivo
AT peigedu activationofcxcl6cxcr12axispromotesthegrowthandmetastasisofosteosarcomacellsinvitroandinvivo
AT yusheng activationofcxcl6cxcr12axispromotesthegrowthandmetastasisofosteosarcomacellsinvitroandinvivo